» Articles » PMID: 17942816

Absolute Quantification of Myocardial Blood Flow with 13N-ammonia and 3-dimensional PET

Overview
Journal J Nucl Med
Specialty Nuclear Medicine
Date 2007 Oct 19
PMID 17942816
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: The aim of this study was to compare 2-dimensional (2D) and 3-dimensional (3D) dynamic PET for the absolute quantification of myocardial blood flow (MBF) with (13)N-ammonia ((13)N-NH(3)).

Methods: 2D and 3D MBF measurements were collected from 21 patients undergoing cardiac evaluation at rest (n = 14) and during standard adenosine stress (n = 7). A lutetium yttrium oxyorthosilicate-based PET/CT system with retractable septa, enabling the sequential acquisition of 2D and 3D images within the same patient and study, was used. All 2D studies were performed by injecting 700-900 MBq of (13)N-NH(3). For 14 patients, 3D studies were performed with the same injected (13)N-NH(3) dose as that used in 2D studies. For the remaining 7 patients, 3D images were acquired with a lower dose of (13)N-NH(3), that is, 500 MBq. 2D images reconstructed by use of filtered backprojection (FBP) provided the reference standard for MBF measurements. 3D images were reconstructed by use of Fourier rebinning (FORE) with FBP (FORE-FBP), FORE with ordered-subsets expectation maximization (FORE-OSEM), and a reprojection algorithm (RP).

Results: Global MBF measurements derived from 3D PET with FORE-FBP (r = 0.97), FORE-OSEM (r = 0.97), and RP (r = 0.97) were well correlated with those derived from 2D FBP (all Ps < 0.0001). The mean +/- SD differences in global MBF measurements between 3D FORE-FBP and 2D FBP and between 3D FORE-OSEM and 2D FBP were 0.01 +/- 0.14 and 0.01 +/- 0.15 mL/min/g, respectively. The mean +/- SD difference in global MBF measurements between 3D RP and 2D FBP was 0.00 +/- 0.16 mL/min/g. The best correlation between 2D PET and 3D PET performed with the lower injected activity was found for the 3D FORE-FBP reconstruction algorithm (r = 0.95, P < 0.001).

Conclusion: For this scanner type, quantitative measurements of MBF with 3D PET and (13)N-NH(3) were in excellent agreement with those obtained with the 2D technique, even when a lower activity was injected.

Citing Articles

Chinese expert consensus on the diagnosis and treatment of coronary microvascular diseases (2023 Edition).

Chen W, Ni M, Huang H, Cong H, Fu X, Gao W MedComm (2020). 2023; 4(6):e438.

PMID: 38116064 PMC: 10729292. DOI: 10.1002/mco2.438.


Definition and epidemiology of coronary microvascular disease.

Bradley C, Berry C J Nucl Cardiol. 2022; 29(4):1763-1775.

PMID: 35534718 PMC: 9345825. DOI: 10.1007/s12350-022-02974-x.


Dual Probes for Positron Emission Tomography (PET) and Fluorescence Imaging (FI) of Cancer.

Yuen R, West F, Wuest F Pharmaceutics. 2022; 14(3).

PMID: 35336019 PMC: 8952779. DOI: 10.3390/pharmaceutics14030645.


Coronary Microvascular Dysfunction: PET, CMR and CT Assessment.

Tonet E, Pompei G, Faragasso E, Cossu A, Pavasini R, Passarini G J Clin Med. 2021; 10(9).

PMID: 33922841 PMC: 8123021. DOI: 10.3390/jcm10091848.


Direct List Mode Parametric Reconstruction for Dynamic Cardiac SPECT.

Shi L, Lu Y, Wu J, Gallezot J, Boutagy N, Thorn S IEEE Trans Med Imaging. 2019; 39(1):119-128.

PMID: 31180845 PMC: 7030971. DOI: 10.1109/TMI.2019.2921969.